FATTY ACID BETA DEGRADATION PATHWAY (PW:0000738)
Description
The degradation of fatty acids represents an essential source of energy; a major route is the mitochondrial beta-oxidation pathway. Before beta-oxidation can proceed, fatty acids need to be 'primed' or activated. The formation of fatty acyl-CoA thioesters is catalyzed by acyl-CoA synthetases in a two-step reaction. There are several acyl-CoA synthetases named after their chain length specificity. Once activated, acyl-CoAs need to reach the mitochondrial matrix where the enzymes of the beta-oxidation pathway are located. The acyl-CoAs, particularly the long-chain ones, cannot easily pass the mitochondrial inner membrane; their translocation is made possible by the CPT system. The acyl moiety is transferred from CoA to carnitine by Cpt1 - an integral membrane protein of the outer mitochondrial membrane. Note that Cpt1 is subject to inhibition by malonyl-CoA, the substrate for the fatty acid biosynthetic pathway. The translocase (Slc25a20) facilitates the translocation of acylcarnitine across the mitochondrial inner membrane where Cpt2 catalyzes the transfer of the acyl group from carnitine to CoA. The acyl-CoA thioesters can now undergo beta-oxidation. The beta-oxidation pathway, generally described as a spiral, consists of a [repeating] cycle of four reactions that produces acetyl-CoA and an acyl-CoA that is two carbon shorter. The spiral repeats itself until the entire acyl-CoA has been broken down to acetyl-CoA. In the first reaction, acyl-CoA is dehydrogenated to trans-2-enoyl-CoA by members of the FAD-containing acyl-CoA dehydrogenase family (Acad). The family contains several members named after their chain-length specificity; of these, the long-chain acyl-CoA dehydrogenase may participate in the beta-oxidation of unsaturated fatty acids. The FADH2 produced in the reaction is re-oxidized by transferring electrons from the dehydrogenase to the FAD group of Etf and from there to Etfdh which feeds the electrons into the electron transport chain thus linking the dehydrogenases to the oxidative phosphorylation pathway culminating in ATP synthesis. In the second reaction, 2-trans-enoyl-CoA is reversibly hydrated to 3-hydroxyacyl-CoA by Echs1. 3-hydroxyacyl-CoA undergoes NAD-dependent dehydrogenation to produce 3-ketoacyl-CoA, a reaction catalyzed by Hadh. The last step involves a thiolase-mediated (Acaa2) cleavage of the thioester bond to release acetyl-CoA and an acyl-CoA which is two carbons shorter and enters another round of the spiral. The last three steps of the beta-oxidation of long-chain acyl-CoA esters - the hydratase, dehydrogenase and thiolase reactions - are carried out by a trifunctional enzyme. While the mono-enzymes are soluble matrix proteins, the trifunctional enzyme is associated with the inner mitochondrial membrane. Disorders of the beta-oxidation pathway have been associated with several conditions.
To see the ontology report for GViewer, annotations and download, click here [Click to see the ontology report for associated GO term -
GO:0006635 , related Kegg map -
map00071 ]
...(less)
Pathway Diagram:
Genes in Pathway:
G
Abcd1
ATP binding cassette subfamily D member 1
ISO
SMPDB
SMP:00052
NCBI chr X:151,428,334...151,450,115
Ensembl chr X:151,428,578...151,450,115
G
Abcd2
ATP binding cassette subfamily D member 2
ISO
SMPDB
SMP:00052
NCBI chr 7:122,263,034...122,311,642
Ensembl chr 7:122,263,032...122,311,642
G
Acaa2
acetyl-CoA acyltransferase 2
IDA ISO
SMPDB RGD
PMID:11879205
SMP:00480 SMP:00481 SMP:00482, RGD:2317624
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
G
Acad9
acyl-CoA dehydrogenase family, member 9
ISO
RGD
PMID:14728676
RGD:2317589
NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547
G
Acadl
acyl-CoA dehydrogenase, long chain
ISO IDA
SMPDB RGD
PMID:14728676 PMID:3968063
SMP:00480 SMP:00482, RGD:2317589 , RGD:2317678
NCBI chr 9:68,333,981...68,372,149
Ensembl chr 9:68,333,980...68,372,220
G
Acadm
acyl-CoA dehydrogenase medium chain
ISO IDA
SMPDB RGD
PMID:14728676 PMID:3968063
SMP:00481, RGD:2317589 , RGD:2317678
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
G
Acads
acyl-CoA dehydrogenase short chain
ISO IDA
SMPDB RGD
PMID:14728676 PMID:3968063
SMP:00480, RGD:2317589 , RGD:2317678
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
G
Acadvl
acyl-CoA dehydrogenase, very long chain
ISO IMP
RGD
PMID:14728676 PMID:15850553
RGD:2317589 , RGD:2317683
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
G
Acat1
acetyl-CoA acetyltransferase 1
ISO
SMPDB
SMP:00480
NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855
G
Acsl1
acyl-CoA synthetase long-chain family member 1
ISO
SMPDB RGD
PMID:17762044
SMP:00052 SMP:00482, RGD:2317576
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Acsl3
acyl-CoA synthetase long-chain family member 3
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
G
Acsl4
acyl-CoA synthetase long-chain family member 4
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
G
Acsl5
acyl-CoA synthetase long-chain family member 5
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr 1:254,289,513...254,336,608
Ensembl chr 1:254,292,521...254,336,607
G
Acsl6
acyl-CoA synthetase long-chain family member 6
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr10:38,439,914...38,501,182
Ensembl chr10:38,440,080...38,498,757
G
Acsm1
acyl-CoA synthetase medium-chain family member 1
ISO
SMPDB
SMP:00481
NCBI chr 1:173,985,715...174,020,565
Ensembl chr 1:173,984,672...174,025,495
G
Acsm2
acyl-CoA synthetase medium-chain family member 2
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116
G
Acsm3
acyl-CoA synthetase medium-chain family member 3
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
G
Acsm4
acyl-CoA synthetase medium-chain family member 4
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr 1:174,053,931...174,078,345
Ensembl chr 1:174,053,931...174,078,341
G
Acss1
acyl-CoA synthetase short-chain family member 1
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
G
Acss2
acyl-CoA synthetase short-chain family member 2
ISO
RGD
PMID:17762044
RGD:2317576
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
G
Acss3
acyl-CoA synthetase short-chain family member 3
ISO
SMPDB
SMP:00480
NCBI chr 7:42,241,261...42,450,209
Ensembl chr 7:42,242,652...42,450,230
G
Cpt1a
carnitine palmitoyltransferase 1A
TAS ISO
SMPDB RGD
PMID:19430727
SMP:00482, RGD:2317584
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Cpt1b
carnitine palmitoyltransferase 1B
ISO
RGD
PMID:19430727
RGD:2317584
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
G
Cpt2
carnitine palmitoyltransferase 2
TAS ISO
SMPDB RGD
PMID:19430727
SMP:00052 SMP:00482, RGD:2317584
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
G
Crat
carnitine O-acetyltransferase
ISO
SMPDB
SMP:00052
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
G
Crot
carnitine O-octanoyltransferase
ISO
SMPDB
SMP:00052
NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
G
Echs1
enoyl-CoA hydratase, short chain 1
IMP ISO
SMPDB RGD
PMID:12379132
SMP:00480 SMP:00481 SMP:00482, RGD:2317616
NCBI chr 1:194,895,036...194,903,863
Ensembl chr 1:194,895,036...194,903,884
G
Etfa
electron transfer flavoprotein subunit alpha
ISO
RGD
PMID:14728676
RGD:2317589
NCBI chr 8:55,835,115...55,891,890
Ensembl chr 8:55,835,134...55,891,969
G
Etfb
electron transfer flavoprotein subunit beta
ISO
RGD
PMID:14728676
RGD:2317589
NCBI chr 1:93,851,908...93,866,072
Ensembl chr 1:93,851,858...93,866,068
G
Etfdh
electron transfer flavoprotein dehydrogenase
ISO
RGD
PMID:14728676
RGD:2317589
NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745
G
Hadh
hydroxyacyl-CoA dehydrogenase
IMP ISO
SMPDB RGD
PMID:17491019
SMP:00480 SMP:00481 SMP:00482, RGD:2302227
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
ISO
SMPDB RGD
PMID:10816122
SMP:00481 SMP:00482, RGD:2317625
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
ISO
SMPDB RGD
PMID:10816122
SMP:00481 SMP:00482, RGD:2317625
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
G
Hsd17b10
hydroxysteroid (17-beta) dehydrogenase 10
ISO
SMPDB
SMP:00480
NCBI chr X:21,089,142...21,091,603
Ensembl chr X:21,089,122...21,109,488
G
Pex11g
peroxisomal biogenesis factor 11 gamma
ISO
SMPDB
SMP:00052
NCBI chr12:1,502,606...1,532,347
Ensembl chr12:1,503,646...1,512,585
G
Pex13
peroxisomal biogenesis factor 13
ISO
SMPDB
SMP:00052
NCBI chr14:97,602,829...97,621,233
Ensembl chr14:97,603,539...97,621,262
G
Pex14
peroxisomal biogenesis factor 14
ISO
SMPDB
SMP:00052
NCBI chr 5:159,399,776...159,536,260
Ensembl chr 5:159,399,776...159,536,272
G
Slc25a20
solute carrier family 25 member 20
ISO
SMPDB RGD
PMID:19430727
SMP:00052 SMP:00481 SMP:00482, RGD:2317584
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
Pathway Gene Annotations
Disease Annotations Associated with Genes in the fatty acid beta degradation pathway
Abcd1 Addison's disease , adrenoleukodystrophy , autistic disorder , autosomal hemophilia A , Barth syndrome , cerebral creatine deficiency syndrome 1 , Chromosome Xq28 Duplication Syndrome , COVID-19 , deafness, dystonia, and cerebral hypomyelination , dyskeratosis congenita , Ehlers-Danlos syndrome kyphoscoliotic type 1 , Emery-Dreifuss muscular dystrophy , encephalitis , factor VIII deficiency , favism , genetic disease , immunodeficiency 33 , intellectual disability , Nervous System Malformations , Neurologic Gait Disorders , paraplegia , periventricular nodular heterotopia , peroxisome biogenesis disorder 2B , severe congenital encephalopathy due to MECP2 mutation , Splenomegaly , syndromic X-linked intellectual disability Lubs type , X-linked spondyloepimetaphyseal dysplasia Abcd2 Colorectal Neoplasms , hypothyroidism Acaa2 adult respiratory distress syndrome , basal cell carcinoma , intellectual disability , osteoarthritis Acad9 alkaptonuria , Charcot-Marie-Tooth disease type 2B , genetic disease , immunodeficiency 21 , mitochondrial complex I deficiency , nuclear type mitochondrial complex I deficiency 20 , Primary Lymphedema with Myelodysplasia Acadl basal cell carcinoma , Long-Chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency , Neurodevelopmental Disorders , primary pulmonary hypertension , trichorhinophalangeal syndrome type I , very long chain acyl-CoA dehydrogenase deficiency Acadm Congenital Hydrocephalus 2, with or without Brain or Eye Anomalies , genetic disease , Liver Failure , medium chain acyl-CoA dehydrogenase deficiency , metabolic dysfunction-associated steatotic liver disease , obesity , perinatal necrotizing enterocolitis , Weight Gain Acads alcohol use disorder , congestive heart failure , genetic disease , maturity-onset diabetes of the young type 1 , short chain acyl-CoA dehydrogenase deficiency , type 2 diabetes mellitus Acadvl Alzheimer's disease , autism spectrum disorder , Autosomal Dominant Intellectual Developmental Disorder 62 , Cardiac Arrhythmias , common variable immunodeficiency , congenital myasthenic syndrome 2A , developmental and epileptic encephalopathy 25 , dilated cardiomyopathy , dyskeratosis congenita , Experimental Diabetes Mellitus , familial hypertrophic cardiomyopathy , Faundes-Banka Syndrome , genetic disease , glutaric acidemia I , Heat Stress Disorders , Hypoxia , intellectual disability , Li-Fraumeni syndrome , metabolic dysfunction-associated steatotic liver disease , Metabolic Syndrome , myopathy , Pearson syndrome , Rhabdomyolysis , very long chain acyl-CoA dehydrogenase deficiency , Weissenbacher-Zweymuller syndrome Acat1 arteriosclerosis , ataxia telangiectasia , beta-ketothiolase deficiency , carbohydrate metabolic disorder , chromosome 11 partial duplication syndrome , end stage renal disease , Experimental Liver Cirrhosis , genetic disease , intellectual disability , nephrotic syndrome , steatotic liver disease Acsl1 Animal Mammary Neoplasms , carcinoma , cardiomyopathy , Chemical and Drug Induced Liver Injury , Experimental Arthritis , Experimental Diabetes Mellitus , Experimental Liver Cirrhosis , Experimental Mammary Neoplasms , Insulin Resistance , obesity , Starvation Acsl3 asthma , breast cancer , Experimental Allergic Asthma , Experimental Diabetes Mellitus , Inflammation , lung cancer , Neurodevelopmental Disorders , prostate cancer , Sudden Cardiac Death Acsl4 Animal Disease Models , autism spectrum disorder , autistic disorder , autosomal hemophilia A , depressive disorder , Erythema , Experimental Arthritis , factor VIII deficiency , genetic disease , hepatocellular carcinoma , Inflammation , intellectual disability , lung adenocarcinoma , non-syndromic X-linked intellectual disability , non-syndromic X-linked intellectual disability 63 , Prostatic Neoplasms , syndromic X-linked intellectual disability Lubs type Acsl5 Diarrhea 13 , Experimental Arthritis Acsl6 acute myeloid leukemia , amphetamine abuse , Experimental Diabetes Mellitus , familial adenomatous polyposis 1 , Hereditary Neoplastic Syndromes , Inflammation , leukemia , Neurodevelopmental Disorders , schizophrenia , systemic primary carnitine deficiency disease Acsm1 Lung Neoplasms Acsm3 essential hypertension , genetic disease , hypertension , IgA glomerulonephritis , NEURODEVELOPMENTAL DISORDER WITH SPEECH DELAY AND VARIABLE OCULAR ANOMALIES , Neurodevelopmental Disorders , ocular hypertension , Overweight , Prostatic Neoplasms , ulcerative colitis Acsm4 developmental and epileptic encephalopathy 21 , Hyperphosphatemic Familial Tumoral Calcinosis 1 , Klippel-Feil syndrome 3 , lymphoproliferative syndrome 2 , peroxisome biogenesis disorder 2B , Temtamy syndrome Acss1 Experimental Melanoma , Hypothermia Acss2 Experimental Melanoma , glutathione synthetase deficiency , glutatione synthetase deficiency with 5-oxoprolinuria , Inflammation , long QT syndrome , lymphangioleiomyomatosis , morbid obesity , orofacial cleft Cpt1a Aicardi-Goutieres Syndrome 3 , alcoholic hepatitis , atherosclerosis , Breast Neoplasms , Cardiac Fibrosis , Cardiotoxicity , carnitine palmitoyltransferase I deficiency , Chemical and Drug Induced Liver Injury , Chronic Hepatitis C , diabetes mellitus , disease of metabolism , end stage renal disease , Experimental Diabetes Mellitus , genetic disease , Hypoxia , intellectual disability , lipid metabolism disorder , lymphangioleiomyomatosis , metabolic dysfunction-associated steatohepatitis , metabolic dysfunction-associated steatotic liver disease , obesity , Recurrent Infections, with Encephalopathy, Hepatic Dysfunction, and Cardiovascular Malformations , type 2 diabetes mellitus Cpt1b autism spectrum disorder , Cardiomegaly , chromosome 22q13 duplication syndrome , congenital disorder of glycosylation Ig , Experimental Diabetes Mellitus , High Myopia , intellectual disability , Liver Neoplasms , megaconial type congenital muscular dystrophy , metachromatic leukodystrophy , Myocardial Ischemia , narcolepsy , Phelan-McDermid syndrome Cpt2 arthritis , brain disease , carnitine palmitoyltransferase II deficiency , Carnitine Palmitoyltransferase II Deficiency, Infantile , Carnitine Palmitoyltransferase II Deficiency, Lethal Neonatal , Chronic Pain , epilepsy , Flatfoot , genetic disease , Genu Valgum , Late-Onset Carnitine Palmitoyltransferase II Deficiency , lipid metabolism disorder , Metabolic Brain Diseases , microcephaly , Muscle Hypotonia , muscular disease , myopathy , Nervous System Malformations , pancytopenia , Primary Dysautonomias , Rhabdomyolysis , Sinus Tachycardia Crat Carnitine Acetyltransferase Deficiency , developmental and epileptic encephalopathy , dystonia , early infantile epileptic encephalopathy , neurodegeneration with brain iron accumulation , Neurodegeneration with Brain Iron Accumulation 8 , primary coenzyme Q10 deficiency 7 Crot Experimental Liver Cirrhosis , Left Ventricular Hypertrophy , pleomorphic xanthoastrocytoma Echs1 Chemical and Drug Induced Liver Injury , distal 10q deletion syndrome , genetic disease , Leigh disease , mitochondrial short-chain enoyl-CoA hydratase 1 deficiency , obesity , Stomach Neoplasms Etfa Bloom syndrome , colorectal cancer , genetic disease , Glutaric Aciduria 2 , hepatocellular carcinoma , multiple acyl-CoA dehydrogenase deficiency , osteoarthritis , PAPA syndrome , schizophrenia Etfb chronic kidney disease , genetic disease , multiple acyl-CoA dehydrogenase deficiency Etfdh disease of metabolism , genetic disease , hypertrophic cardiomyopathy , megacolon , multiple acyl-CoA dehydrogenase deficiency , myopathy , obesity , spinal muscular atrophy Hadh 3-Hydroxyacyl-CoA Dehydrogenase Deficiency , Congenital Hyperinsulinism , diabetes mellitus , Experimental Diabetes Mellitus , familial hyperinsulinemic hypoglycemia 1 , familial hyperinsulinemic hypoglycemia 4 , genetic disease , hyperinsulinemic hypoglycemia , hyperinsulinism , myocardial infarction , obesity , pre-malignant neoplasm Hadha Alzheimer's disease , Chemical and Drug Induced Liver Injury , COVID-19 , Experimental Diabetes Mellitus , Fetal Growth Retardation , genetic disease , Long-Chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency , metabolic dysfunction-associated steatotic liver disease , mitochondrial trifunctional protein deficiency , mitochondrial trifunctional protein deficiency 1 , Myocardial Ischemia , osteoarthritis , steatotic liver disease , Tatton-Brown-Rahman syndrome Hadhb Alzheimer's disease , Breast Neoplasms , Charcot-Marie-Tooth disease , COVID-19 , genetic disease , heart disease , lipid metabolism disorder , Long-Chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency , metabolic acidosis , mitochondrial metabolism disease , mitochondrial trifunctional protein deficiency , mitochondrial trifunctional protein deficiency 1 , mitochondrial trifunctional protein deficiency 2 , steatotic liver disease , Tatton-Brown-Rahman syndrome Hsd17b10 Alzheimer's disease , Atkin Syndrome , autistic disorder , azoospermia , Cornelia de Lange syndrome 2 , COVID-19 , genetic disease , lung adenocarcinoma , non-syndromic X-linked intellectual disability 1 , osteosarcoma , paraplegia , pheochromocytoma , syndromic X-linked intellectual disability Lubs type , syndromic X-linked intellectual disability type 10 Pex11g hereditary spastic paraplegia 39 , mucolipidosis type IV Pex13 adrenoleukodystrophy , genetic disease , infantile Refsum disease , peroxisomal biogenesis disorder , peroxisome biogenesis disorder 11A , Peroxisome biogenesis disorder 11B , peroxisome biogenesis disorder 1A , Zellweger syndrome Pex14 Charcot-Marie-Tooth disease type 2 , chromosome 1p36 deletion syndrome , genetic disease , immunodeficiency 14 , ovarian cyst , peroxisomal biogenesis disorder , peroxisome biogenesis disorder 13A , peroxisome biogenesis disorder 1A , Peroxisome Biogenesis Disorder, Complementation Group K , Zellweger syndrome Slc25a20 Aicardi-Goutieres Syndrome 1 , autism spectrum disorder , autosomal recessive limb-girdle muscular dystrophy type 2P , carnitine-acylcarnitine translocase deficiency , genetic disease , Progressive Microcephaly with Seizures and Cerebral and Cerebellar Atrophy
3-Hydroxyacyl-CoA Dehydrogenase Deficiency Hadh acute myeloid leukemia Acsl6 Addison's disease Abcd1 adrenoleukodystrophy Abcd1 , Pex13 adult respiratory distress syndrome Acaa2 Aicardi-Goutieres Syndrome 1 Slc25a20 Aicardi-Goutieres Syndrome 3 Cpt1a alcohol use disorder Acads alcoholic hepatitis Cpt1a alkaptonuria Acad9 Alzheimer's disease Acadvl , Hadha , Hadhb , Hsd17b10 amphetamine abuse Acsl6 Animal Disease Models Acsl4 Animal Mammary Neoplasms Acsl1 arteriosclerosis Acat1 arthritis Cpt2 asthma Acsl3 ataxia telangiectasia Acat1 atherosclerosis Cpt1a Atkin Syndrome Hsd17b10 autism spectrum disorder Acadvl , Acsl4 , Cpt1b , Slc25a20 autistic disorder Abcd1 , Acsl4 , Hsd17b10 Autosomal Dominant Intellectual Developmental Disorder 62 Acadvl autosomal hemophilia A Abcd1 , Acsl4 autosomal recessive limb-girdle muscular dystrophy type 2P Slc25a20 azoospermia Hsd17b10 Barth syndrome Abcd1 basal cell carcinoma Acaa2 , Acadl beta-ketothiolase deficiency Acat1 Bloom syndrome Etfa brain disease Cpt2 breast cancer Acsl3 Breast Neoplasms Cpt1a , Hadhb carbohydrate metabolic disorder Acat1 carcinoma Acsl1 Cardiac Arrhythmias Acadvl Cardiac Fibrosis Cpt1a Cardiomegaly Cpt1b cardiomyopathy Acsl1 Cardiotoxicity Cpt1a Carnitine Acetyltransferase Deficiency Crat carnitine palmitoyltransferase I deficiency Cpt1a carnitine palmitoyltransferase II deficiency Cpt2 Carnitine Palmitoyltransferase II Deficiency, Infantile Cpt2 Carnitine Palmitoyltransferase II Deficiency, Lethal Neonatal Cpt2 carnitine-acylcarnitine translocase deficiency Slc25a20 cerebral creatine deficiency syndrome 1 Abcd1 Charcot-Marie-Tooth disease Hadhb Charcot-Marie-Tooth disease type 2 Pex14 Charcot-Marie-Tooth disease type 2B Acad9 Chemical and Drug Induced Liver Injury Acsl1 , Cpt1a , Echs1 , Hadha chromosome 11 partial duplication syndrome Acat1 chromosome 1p36 deletion syndrome Pex14 chromosome 22q13 duplication syndrome Cpt1b Chromosome Xq28 Duplication Syndrome Abcd1 Chronic Hepatitis C Cpt1a chronic kidney disease Etfb Chronic Pain Cpt2 colorectal cancer Etfa Colorectal Neoplasms Abcd2 common variable immunodeficiency Acadvl congenital disorder of glycosylation Ig Cpt1b Congenital Hydrocephalus 2, with or without Brain or Eye Anomalies Acadm Congenital Hyperinsulinism Hadh congenital myasthenic syndrome 2A Acadvl congestive heart failure Acads Cornelia de Lange syndrome 2 Hsd17b10 COVID-19 Abcd1 , Hadha , Hadhb , Hsd17b10 deafness, dystonia, and cerebral hypomyelination Abcd1 depressive disorder Acsl4 developmental and epileptic encephalopathy Crat developmental and epileptic encephalopathy 21 Acsm4 developmental and epileptic encephalopathy 25 Acadvl diabetes mellitus Cpt1a , Hadh Diarrhea 13 Acsl5 dilated cardiomyopathy Acadvl disease of metabolism Cpt1a , Etfdh distal 10q deletion syndrome Echs1 dyskeratosis congenita Abcd1 , Acadvl dystonia Crat early infantile epileptic encephalopathy Crat Ehlers-Danlos syndrome kyphoscoliotic type 1 Abcd1 Emery-Dreifuss muscular dystrophy Abcd1 encephalitis Abcd1 end stage renal disease Acat1 , Cpt1a epilepsy Cpt2 Erythema Acsl4 essential hypertension Acsm3 Experimental Allergic Asthma Acsl3 Experimental Arthritis Acsl1 , Acsl4 , Acsl5 Experimental Diabetes Mellitus Acadvl , Acsl1 , Acsl3 , Acsl6 , Cpt1a , Cpt1b , Hadh , Hadha Experimental Liver Cirrhosis Acat1 , Acsl1 , Crot Experimental Mammary Neoplasms Acsl1 Experimental Melanoma Acss1 , Acss2 factor VIII deficiency Abcd1 , Acsl4 familial adenomatous polyposis 1 Acsl6 familial hyperinsulinemic hypoglycemia 1 Hadh familial hyperinsulinemic hypoglycemia 4 Hadh familial hypertrophic cardiomyopathy Acadvl Faundes-Banka Syndrome Acadvl favism Abcd1 Fetal Growth Retardation Hadha Flatfoot Cpt2 genetic disease Abcd1 , Acad9 , Acadm , Acads , Acadvl , Acat1 , Acsl4 , Acsm3 , Cpt1a , Cpt2 , Echs1 , Etfa , Etfb , Etfdh , Hadh , Hadha , Hadhb , Hsd17b10 , Pex13 , Pex14 , Slc25a20 Genu Valgum Cpt2 glutaric acidemia I Acadvl Glutaric Aciduria 2 Etfa glutathione synthetase deficiency Acss2 glutatione synthetase deficiency with 5-oxoprolinuria Acss2 heart disease Hadhb Heat Stress Disorders Acadvl hepatocellular carcinoma Acsl4 , Etfa Hereditary Neoplastic Syndromes Acsl6 hereditary spastic paraplegia 39 Pex11g High Myopia Cpt1b hyperinsulinemic hypoglycemia Hadh hyperinsulinism Hadh Hyperphosphatemic Familial Tumoral Calcinosis 1 Acsm4 hypertension Acsm3 hypertrophic cardiomyopathy Etfdh Hypothermia Acss1 hypothyroidism Abcd2 Hypoxia Acadvl , Cpt1a IgA glomerulonephritis Acsm3 immunodeficiency 14 Pex14 immunodeficiency 21 Acad9 immunodeficiency 33 Abcd1 infantile Refsum disease Pex13 Inflammation Acsl3 , Acsl4 , Acsl6 , Acss2 Insulin Resistance Acsl1 intellectual disability Abcd1 , Acaa2 , Acadvl , Acat1 , Acsl4 , Cpt1a , Cpt1b Klippel-Feil syndrome 3 Acsm4 Late-Onset Carnitine Palmitoyltransferase II Deficiency Cpt2 Left Ventricular Hypertrophy Crot Leigh disease Echs1 leukemia Acsl6 Li-Fraumeni syndrome Acadvl lipid metabolism disorder Cpt1a , Cpt2 , Hadhb Liver Failure Acadm Liver Neoplasms Cpt1b long QT syndrome Acss2 Long-Chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency Acadl , Hadha , Hadhb lung adenocarcinoma Acsl4 , Hsd17b10 lung cancer Acsl3 Lung Neoplasms Acsm1 lymphangioleiomyomatosis Acss2 , Cpt1a lymphoproliferative syndrome 2 Acsm4 maturity-onset diabetes of the young type 1 Acads medium chain acyl-CoA dehydrogenase deficiency Acadm megacolon Etfdh megaconial type congenital muscular dystrophy Cpt1b metabolic acidosis Hadhb Metabolic Brain Diseases Cpt2 metabolic dysfunction-associated steatohepatitis Cpt1a metabolic dysfunction-associated steatotic liver disease Acadm , Acadvl , Cpt1a , Hadha Metabolic Syndrome Acadvl metachromatic leukodystrophy Cpt1b microcephaly Cpt2 mitochondrial complex I deficiency Acad9 mitochondrial metabolism disease Hadhb mitochondrial short-chain enoyl-CoA hydratase 1 deficiency Echs1 mitochondrial trifunctional protein deficiency Hadha , Hadhb mitochondrial trifunctional protein deficiency 1 Hadha , Hadhb mitochondrial trifunctional protein deficiency 2 Hadhb morbid obesity Acss2 mucolipidosis type IV Pex11g multiple acyl-CoA dehydrogenase deficiency Etfa , Etfb , Etfdh Muscle Hypotonia Cpt2 muscular disease Cpt2 myocardial infarction Hadh Myocardial Ischemia Cpt1b , Hadha myopathy Acadvl , Cpt2 , Etfdh narcolepsy Cpt1b nephrotic syndrome Acat1 Nervous System Malformations Abcd1 , Cpt2 neurodegeneration with brain iron accumulation Crat Neurodegeneration with Brain Iron Accumulation 8 Crat NEURODEVELOPMENTAL DISORDER WITH SPEECH DELAY AND VARIABLE OCULAR ANOMALIES Acsm3 Neurodevelopmental Disorders Acadl , Acsl3 , Acsl6 , Acsm3 Neurologic Gait Disorders Abcd1 non-syndromic X-linked intellectual disability Acsl4 non-syndromic X-linked intellectual disability 1 Hsd17b10 non-syndromic X-linked intellectual disability 63 Acsl4 nuclear type mitochondrial complex I deficiency 20 Acad9 obesity Acadm , Acsl1 , Cpt1a , Echs1 , Etfdh , Hadh ocular hypertension Acsm3 orofacial cleft Acss2 osteoarthritis Acaa2 , Etfa , Hadha osteosarcoma Hsd17b10 ovarian cyst Pex14 Overweight Acsm3 pancytopenia Cpt2 PAPA syndrome Etfa paraplegia Abcd1 , Hsd17b10 Pearson syndrome Acadvl perinatal necrotizing enterocolitis Acadm periventricular nodular heterotopia Abcd1 peroxisomal biogenesis disorder Pex13 , Pex14 peroxisome biogenesis disorder 11A Pex13 Peroxisome biogenesis disorder 11B Pex13 peroxisome biogenesis disorder 13A Pex14 peroxisome biogenesis disorder 1A Pex13 , Pex14 peroxisome biogenesis disorder 2B Abcd1 , Acsm4 Peroxisome Biogenesis Disorder, Complementation Group K Pex14 Phelan-McDermid syndrome Cpt1b pheochromocytoma Hsd17b10 pleomorphic xanthoastrocytoma Crot pre-malignant neoplasm Hadh primary coenzyme Q10 deficiency 7 Crat Primary Dysautonomias Cpt2 Primary Lymphedema with Myelodysplasia Acad9 primary pulmonary hypertension Acadl Progressive Microcephaly with Seizures and Cerebral and Cerebellar Atrophy Slc25a20 prostate cancer Acsl3 Prostatic Neoplasms Acsl4 , Acsm3 Recurrent Infections, with Encephalopathy, Hepatic Dysfunction, and Cardiovascular Malformations Cpt1a Rhabdomyolysis Acadvl , Cpt2 schizophrenia Acsl6 , Etfa severe congenital encephalopathy due to MECP2 mutation Abcd1 short chain acyl-CoA dehydrogenase deficiency Acads Sinus Tachycardia Cpt2 spinal muscular atrophy Etfdh Splenomegaly Abcd1 Starvation Acsl1 steatotic liver disease Acat1 , Hadha , Hadhb Stomach Neoplasms Echs1 Sudden Cardiac Death Acsl3 syndromic X-linked intellectual disability Lubs type Abcd1 , Acsl4 , Hsd17b10 syndromic X-linked intellectual disability type 10 Hsd17b10 systemic primary carnitine deficiency disease Acsl6 Tatton-Brown-Rahman syndrome Hadha , Hadhb Temtamy syndrome Acsm4 trichorhinophalangeal syndrome type I Acadl type 2 diabetes mellitus Acads , Cpt1a ulcerative colitis Acsm3 very long chain acyl-CoA dehydrogenase deficiency Acadl , Acadvl Weight Gain Acadm Weissenbacher-Zweymuller syndrome Acadvl X-linked spondyloepimetaphyseal dysplasia Abcd1 Zellweger syndrome Pex13 , Pex14